Mitsubishi Pharma

From Wikipedia, the free encyclopedia

Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社, Mitsubishi Werufāma Kabushiki-gaisha^?) is a Japanese pharmaceuticals company, a subsidiary of Mitsubishi Chemical Holdings Corporation. It was formed in 2001 from the merger of Mitsubishi-Tokyo Pharamceuticals and Welfide Corporation.

[edit] History

Takeda Kasei Co., Ltd. was established in 1940 by Chobei Takeda & Co., Ltd. (present-day Takeda Pharmaceutical Company) and Nippon Kasei Chemical Co. Ltd. (present-day Mitsubishi Chemical Corporation) and built its first plant in Higashi-Yoshitomi-mura, Fukuoka Prefecture. The company changed its name in 1952 to Yoshitomi Pharmaceutical Co., Ltd. in 1946 and listed on Tokyo and Osaka stock exchanges in 1949.

The Blood Plasma Corporation of Japan was established in 1950 with head office and plant in Osaka. This company changed its name to Green Cross Corporation in 1964.

Green Cross Corporation was acquired by Yoshitomi Pharmaceutical in 1998, changing its name to Welfide Corporation in 2000.

In 1901 Motosaburo Tanabe established a pharmacy in Tokyo, which was incorporated in 1921 as Motosaburo Tanabe Shoten, changing its name in 1943 to Tokyo Tanabe Pharmaceuticals Co., Ltd.

Nippon Tar Industries was established in 1921, becoming Mitsubishi Chemical Industries, Ltd. in 1952. This company established a business alliance with Tokyo Tanabe Pharmaceuticals Co. in 1981, and changed its name to Mitsubishi Chemical Corporation following the 1984 merger with Mitsubishi Petrochemical Co., Ltd.

Mitsubishi Chemical Corporation and Tokyo Tanabe Pharmaceuticals Co. merged formally in 1999 and formed Mitsubishi-Tokyo Pharmaceuticals, Inc., to take over the combined pharmaceutical operations of the two companies.

Mitsubishi-Tokyo Pharamceuticals and Welfide Corporation merged in 2001 to establish Mitsubishi Pharma Corporation, and this company joined again with Mitsubishi Chemical Corporation to create Mitsubishi Chemical Holdings Corporation in October 2005.